文献速递多重用药

减少潜在不适当用药的教育干预的成本效果分析

Cost-effectiveness of an educational intervention to reduce potentially inappropriate medication.
PubMed 文献 · Age Ageing · 2022-01-01

该研究基于整群随机试验,对20个辅助生活设施病区227名常住居民进行12个月经济学评价,比较针对护理人员和咨询医师的互动式教育干预与常规治疗。结果显示干预组成本更低但QALY略低,增量成本效果比(ICER)大于€80,000/QALY,减少潜在不适当用药(PIM)或生活质量获益似未转化为QALY改善。

要点

  • 基础案例ICER大于€80,000/QALY,干预相比常规治疗成本更低但效果更差。
  • 减少PIM使用或生活质量获益未转化为QALY改善,需更好理解减少PIM对健康结局的影响。

核心结论

  • 教育干预相比常规治疗在12个月时估计成本更低且QALY更少,但结果存在不确定性。
  • 减少PIM使用或生活质量获益似乎未转化为QALY的改善。

研究设计与样本

  • 整群随机试验(cRCT)的经济学评价,纳入20个辅助生活设施病区的227名常住居民。
  • 干预为针对护理人员和咨询医师的激活式互动培训课程,对照为常规治疗(TAU)。
  • 从医疗保健视角估算12个月内的医疗服务使用成本和干预成本,计算每名参与者的QALY增量成本效果比(ICER)。
  • 采用自举法成本效果平面和单因素敏感性分析评估估计的不确定性。

主要发现

  • 基础案例ICER大于€80,000/QALY。

临床怎么用

  • 教育干预减少PIM使用的同时需关注其对QALY等健康结局的实际影响,不能仅以PIM变化作为效果指标。

局限性

  • 结果存在一定不确定性,需进一步理解减少PIM使用对健康结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Educational interventions can reduce potentially inappropriate medication (PIM) use in older people. Their effectiveness has been measured mainly as changes in PIM use. In this economic evaluation, we analyse the impact of an educational intervention in terms of costs and quality-adjusted life years (QALYs). METHODS: The educational intervention consisted of activating and interactive training sessions for nursing staff and consulting physicians, and was compared with treatment as usual (TAU). Participants (n = 227) in a cluster randomised trial (cRCT) were residents living permanently in assisted living facilities (n = 20 wards). For economic evaluation, participants' healthcare service use costs and costs for the intervention were estimated for a 12 month period.Incremental cost-effectiveness ratios (ICERs) were estimated for QALYs per participant. Cost-effectiveness analysis was conducted from a healthcare perspective. A bootstrapped cost-effectiveness plane and one-way sensitivity analysis were undertaken to analyse the uncertainty surrounding the estimates. RESULTS: The educational intervention was estimated to be less costly and less effective in terms of QALYs than TAU at the 12 month follow-up [incremental costs -€1,629, confidence interval (CI) -€5,489 to €2,240; incremental effect -0.02, CI -0.06 to 0.02]. The base case ICER was >€80,000/QALY. CONCLUSION: The educational intervention was estimated to be less costly and less effective in terms of QALYs compared with TAU, but the results are subject to some uncertainties. Reduction in PIM use or benefits in quality of life did not seem to translate into improvements in QALYs. Our findings emphasise the need for better understanding of the impact of decreasing PIM use on health outcomes.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Rantsi M, Pitkälä KH, Kautiainen H, et al. Cost-effectiveness of an educational intervention to reduce potentially inappropriate medication. Age Ageing. 2022. PMID: 35604803. doi:10.1093/ageing/afac112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。